Clinical nutrition offers nutritional and metabolic care to patients. Malnutrition refers to deficient, excess or immoderate intake of energy and/or nutrients by an individual. It is global healthcare challenge, adversely changing the lives of millions of people. Undernutrition is an important reason behind poor growth, stunting, which affects more than 149 million children of less than 5 years of age across the world. Also, there are 40 million overweight children globally.
GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1402
In a recent study in China, it was found that out of elderly people infected with the novel corona virus, 27.5% were at the risk of malnutrition and 52.7% were in the malnutrition category. Thus, the prevalence of malnutrition in elderly patients with the disease was high, and nutritional care should be increased during the treatment.
Market Insights
Clinical nutrition is a predominant domain of healthcare for patients in order to deal with sickness, abrasions, surgery and for proper recovery. It aids in the prevention of malnutrition, reconstruction of body tissue and increasing body immunity. Clinical nutrition is a type of pharmaceutical products given to patients in the form of requisite amount of nutrients such as proteins, vitamins and minerals to keep them healthy. Increasing incidence of metabolic disorders and increased expenses on healthcare are boosting the growth of the clinical nutrition market.
According to Report Ocean study, Global Clinical Nutrition Market is valued at approximately US$33 billions in 2019 and is expected to grow at a rate of more than 5.3% over the forecasted period 2020-2027.
This report forecasts growth of Clinical Nutrition Market at global level and provides an insight of the latest trends. For the current analysis, Report Ocean has segmented the market by route of administration, by application and by end users.
- Route of administration
- Oral
- Enteral
- Parenteral
Application
- Cancer
- Neurological diseases
- Gastrointestinal disorders
- Metabolic disorders
- Other disorders
End users
- Paediatric
- Adults
- Geriatric
The factors like rise in prevalence of chronic conditions and interest of people to develop a healthy diet have resulted in escalated demand for clinical nutrition and thus leads to market expansion. Moreover, increasing prevalence of cancer also plays a major role in boosting the market growth. However, lack of awareness and stringent regulations are the major factors hampering the market growth.
The oral and enteral segment holds most of the market share. These exhibit several advantages including safety, pain avoidance, versatility and ease of ingestion. Moreover, they are associated with lesser septic and metabolic issues compared to parenteral nutrition.
The cancer is projected to be the fastest growing segment during the forecast period. According to the International Agency for Research on Cancer (IARC), approximately 17 million new cancer cases with almost 9.5 million cancer deaths were reported throughout the world in the year 2018 and the global cancer burden is expected to grow to almost 27.5 million new cancer cases with around 16.3 million cancer deaths by the year 2040. The rise in cancer segment is due to nutritional deficiency that arises in patients as a result of chemotherapy, radiation therapy, surgery, hormone therapy, stem cell transplant and immunotherapy.
The pediatric segment accounted for the largest share in 2018, and will continue to follow the same trend during the forecast period. Each year, approximately 5.9 million children around the world die before they reach the age of five and malnutrition is associated with increased risk of death. It was found in a study that 32.8 million children worldwide are affected by moderate acute malnutrition whereas, 18.7 million children worldwide are affected by severe acute malnutrition.
The regional analysis of the global Clinical Nutrition market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia-Pacific is the leading region worldwide in terms of market share due to rise in adoption rate of clinical nutrition products, along with the presence of a considerable number of manufacturers in the region. Around 76% of currently active nutrition clinical trials are in North America and Europe and 24% for the rest of the world. Middle East accounted for 4%, standing at fourth position after North America, Europe and Asia.
Major market players of clinical nutrition included in this report are Abbott Laboratories, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Nestle S.A., Baxter International Inc., Fresenius SE & Co. KGaA, Danone Nutricia, Perrigo Company Plc, Pfizer Inc., Hero Nutritionals Inc., and others.
Marketed Products
EleCare is amino acid-based formula for infants who are intolerant to hydrolyzed protein. The formula is developed by Abbott Laboratories to provide nutrition in certain patients with severe food allergies or other conditions such as gastrointestinal disorders, short bowel syndrome, or malabsorption in which an amino acid-based diet is required. This one of the hypoallergenic baby formulas approved by the US Food and Drug Administration.
IsosourceⓇ Energy, an energy supplement from Nestle S.A. can be administered through enteral route and is required for patients with high energy and protein demands. Enteral nutrition formulas may be the sole source of nutrition or a partial supplement to the diet. It is a mixture of soluble and insoluble fibers.
Portagen from Mead Johnson Nutrition Company is a nutritional milk powder for children and adults. It is a protein-based powder for individuals with defects in fat absorption. It contains milk proteins along with medium-chain triglycerides. Portagen is not nutritionally complete and is not recommended to use as infant formula.
Clinimix are sulphite free Injections used to deliver from parenteral route of administration and a ready-to-use amino acids in solution for adult and pediatric use. It is developed by Baxter International Inc. .
Impact of Covid-19 on Clinical Nutrition Market
During the COVID-19 crisis, when most of markets are facing difficulties due to stringent regulations which should be followed to avoid the widespread of infection, clinical nutrition industry is having a quantum leap. Since it is beneficial for the COVID-19 patient’s respiratory issues, thus several government bodies are accepting its value thereby, strengthening the demand for clinical nutrition products.
Have Any Query? Ask Our Experts: https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1402
Download Detailed Sample Pages with COVID-19 Impact Analysis at https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1402
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean
Name: Nishi Sharma
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
